| Kranthi Kiran Reddy Sitammagari, MD | |
|
600 Hospital Dr, Monroe, NC 28112-6000 | |
| (704) 993-2240 | |
| Not Available |
| Full Name | Kranthi Kiran Reddy Sitammagari |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 18 Years |
| Location | 600 Hospital Dr, Monroe, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1184988776 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 2015-01630 (North Carolina) | Secondary |
| 207R00000X | Internal Medicine | 2015-01630 (North Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Atrium Health Union | Monroe, NC | Hospital |
| Onslow Memorial Hospital | Jacksonville, NC | Hospital |
| Carolinas Medical Center-pineville | Charlotte, NC | Hospital |
| Atrium Health Cleveland | Shelby, NC | Hospital |
| Atrium Health Anson | Wadesboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carolinas Physicians Network Inc | 3375449655 | 1613 |
| Apogee Medical Group North Carolina | 7719162254 | 58 |
News Archive
DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer's disease covering a total of 32 countries.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.
Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.
Cipher Pharmaceuticals Inc. today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review. The Company expects the review to be completed by early 2011.
› Verified 5 days ago
| Entity Name | Carolinas Physicians Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477878890 PECOS PAC ID: 3375449655 Enrollment ID: O20031219000455 |
News Archive
DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer's disease covering a total of 32 countries.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.
Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.
Cipher Pharmaceuticals Inc. today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review. The Company expects the review to be completed by early 2011.
› Verified 5 days ago
| Entity Name | Apogee Medical Group North Carolina |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043518228 PECOS PAC ID: 7719162254 Enrollment ID: O20110427000840 |
News Archive
DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer's disease covering a total of 32 countries.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.
Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.
Cipher Pharmaceuticals Inc. today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review. The Company expects the review to be completed by early 2011.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kranthi Kiran Reddy Sitammagari, MD Po Box 19305, Charlotte, NC 28219-9305 Ph: () - | Kranthi Kiran Reddy Sitammagari, MD 600 Hospital Dr, Monroe, NC 28112-6000 Ph: (704) 993-2240 |
News Archive
DiaGenic ASA and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer's disease covering a total of 32 countries.
Biovail Corporation today announced financial results for the three-month and nine-month periods ended September 30, 2009. To the extent that this news release contains forward-looking statements, investors are cautioned that these statements are based on the Company's current views, and actual outcomes are not certain.
A research team led by pediatric blood and marrow transplantation experts Mark Osborn, Ph.D. and Jakub Tolar, M.D., Ph.D. from the Masonic Cancer Center, University of Minnesota, have discovered a remarkable new way to repair genetic defects in the skin cells of patients with the skin disease epidermolysis bullosa.
Antigenics Inc. today announced that effective immediately it is changing its name to Agenus Inc. The company's stock will continue to be traded on NASDAQ under the symbol AGEN. The new name reflects the broadening of the company's product portfolio of clinical candidates beyond autologous antigen-based vaccines, as well as its commitment to actively pursuing licensing opportunities to leverage its development capabilities and expand its product portfolio.
Cipher Pharmaceuticals Inc. today announced that its New Drug Submission (NDS) to Health Canada for CIP-TRAMADOL ER, its extended-release formulation of tramadol, has been accepted for review. The Company expects the review to be completed by early 2011.
› Verified 5 days ago
Dr. Thomas Joseph Bice, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1969 Wellness Blvd, Monroe, NC 28110 Phone: 704-316-5775 Fax: 704-316-5815 | |
Rajiv Paudel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Charles H Hoover Iii, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1420 E Franklin St, Monroe, NC 28112 Phone: 704-289-8427 Fax: 704-283-5522 | |
Pascale Anglade, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1663 Campus Park Dr, Suite D, Monroe, NC 28112 Phone: 704-291-2488 Fax: 704-283-0160 | |
Pawan Damodhar Sarda, M.D. Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 | |
Santhosh Reddy Devarapally, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1550 Faulk St, Ste 3100, Monroe, NC 28112 Phone: 704-667-3410 | |
Dr. James Wayne Roberts, MD Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 1640 E Roosevelt Blvd, Monroe, NC 28112 Phone: 704-226-0500 Fax: 704-226-0599 |